Loading insider details...
Beta
Latest Form 4 (May 12, 2026): Purchase of 5,000 ODTX shares, $100.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | Odyssey Therapeutics, Inc. (ODTX) | Purchase | 5,000 | $100.0K |
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 3,547 | $1.72M |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 8,269 | n/a |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 9,012 | n/a |
| Dec 5, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 63,781 | $5.52M |
| Nov 17, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 19,688 | $1.79M |
| Feb 19, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 6,066 | $2.81M |
| Feb 14, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 7,209 | n/a |
| Feb 6, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 15,414 | n/a |
| Sep 4, 2024 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 3,784 | $1.89M |